Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gene therapy for prostate cancer.

J R Gingrich1, R D Chauhan, M S Steiner

  • 1Department of Urology, University of Tennessee Medical Center, 956 Court Avenue, H216, Memphis, TN 38163, USA. Jgingrich@utmem.edu

Current Oncology Reports
|August 8, 2001
PubMed
Summary

Gene therapy offers a novel approach to combat prostate cancer by targeting gene expression. While initial clinical trials show safety, further research is needed to confirm its long-term effectiveness in treating this malignancy.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Transgenic overexpression of endogenous FLOWERING LOCUS T-like gene MeFT1 produces early flowering in cassava.

PloS one·2020
Same author

An unusual case of axillary lymphadenopathy.

Medical journal, Armed Forces India·2015
Same author

Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2013
Same author

Risk factors for concomitant involvement of the female urethra at cystectomy for malignancy.

Urologic oncology·2011
Same author

Molecular insights into altered cell cycle regulation and genitourinary malignancy.

Urologic oncology·2011
Same author

Prostate cancer cells lose their sensitivity to TGFβI growth inhibition with tumor progression.

Urologic oncology·2011

Area of Science:

  • Molecular biology
  • Genetics
  • Oncology

Background:

  • Basic research is elucidating the molecular mechanisms underlying normal and abnormal cellular processes.
  • Gene therapy has emerged as a strategy to modulate gene expression involved in cancer development.
  • Prostate cancer involves malignant transformation of prostatic epithelial cells, a target for gene therapy.

Purpose of the Study:

  • To review recent preclinical research in gene therapy for prostate cancer.
  • To discuss current therapeutic strategies utilizing gene therapy.
  • To present recent findings from gene therapy clinical trials for prostate cancer.

Main Methods:

  • Review of preclinical studies on gene therapy for prostate cancer.
  • Analysis of current gene therapy approaches for prostate cancer treatment.

Related Experiment Videos

  • Compilation and summary of results from clinical trials of gene therapy in prostate cancer patients.

    • Main Results:

    • Gene therapy has demonstrated relative safety in initial clinical trials for prostate cancer.
    • Definitive evidence of durable therapeutic efficacy for gene therapy in prostate cancer is still pending.
    • Ongoing research continues to explore the potential of gene therapy in managing prostate cancer.

    Conclusions:

    • Gene therapy is a promising, albeit developing, field for prostate cancer treatment.
    • Further clinical investigation is essential to establish the efficacy and long-term benefits of gene therapy.
    • The review highlights the progress and future directions of gene therapy in oncology.